MedPath

Financial incentives for hypertension control in China (FIHCC study)

Not Applicable
Completed
Conditions
Hypertension
Circulatory System
Registration Number
ISRCTN13467677
Lead Sponsor
Shengjing Hospital of China Medical University
Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35862120/ (added 22/07/2022) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32014046/ (added 10/06/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
207
Inclusion Criteria

1. Aged 35 - 75 years
2. Uncontrolled hypertensive patients (SBP/DBP = 140/90mmHg)
3. Have WeChat and use skillfully
4. Local residents, who live in local places for more than 12 months
5. Voluntarily joined and signed informed consents

Exclusion Criteria

1. Pregnant women or women who are planning to become pregnant in the next year
2. Plans to move from the neighborhood in the next year
3. Malignant tumors or severe liver, kidney dysfunction
4. Can not be proficient in using WeChat
5. Secondary hypertension patients
6. Disagree to participate in the study or cannot give the informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic blood pressure at the baseline and after 1, 3, 6, and 12 months
Secondary Outcome Measures
NameTimeMethod
1. Diatolic blood pressure measured using blood pressure monitors at the baseline, and after 1, 3, 6 and 12 months<br>2. The proportion of hypertension control (BP <140/90 mmHg) at 1, 3, 6, and 12 months<br>3. Medication adherence at the baseline, and after 1, 3, 6, and 12 months<br>4. Body mass index assessed by dividing weight in kg by height in metres at the baseline, and after 1, 3, 6, and 12 months<br>5. Physical activity at the baseline, and after 1, 3, 6, and 12 months<br>6. Counseling frequency at the baseline, and after 1, 3, 6, and 12 months<br>7. Counseling content at the baseline, and after 1, 3, 6, and 12 months<br>8. Number of steps in WeChat at the baseline, and after 1, 3, 6, and 12 months<br>9. Pulmonary function at the baseline and after 12 months<br>10. Pulse wave velocity at the baseline and after 12 months<br>11. Ankle brachial index at the baseline and after 12 months<br>12. Cost-effectiveness
© Copyright 2025. All Rights Reserved by MedPath